NCT03575312View on ClinicalTrials.gov

Pharmacokinetics of Enrofloxacin in Plasma and Urine

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 27, 2018

Primary Completion Date

June 4, 2018

Study Completion Date

August 30, 2018

Conditions
Healthy
Interventions
DRUG

Enrofloxacin

dermal application, inhalation rsp. oral administration of Enrofloxacin

Trial Locations (1)

30625

Fraunhofer Institute for Toxicology and Experimental Medicine, Hanover

All Listed Sponsors
collaborator

Federal Institute for Occupational Safety and Health (BAuA)/Germany)

UNKNOWN

lead

Fraunhofer-Institute of Toxicology and Experimental Medicine

OTHER

NCT03575312 - Pharmacokinetics of Enrofloxacin in Plasma and Urine | Biotech Hunter | Biotech Hunter